AIBODY pioneers the frontier of digital physiology modelling. Boasting decades of cumulative expertise in healthcare, human physiology research and computational simulation, the UK tech company crafts exceptionally accurate digital representations of the human body's inner workings. What truly distinguishes AIBODY is its groundbreaking subcellular modelling technique — a proprietary approach that elevates their technology above their competition.
In contrast to competitors, AIBODY has a bottom-up approach to digital physiology. They model intricate biochemical and biomechanical transformations within individual cells. This allows for nuanced interventions, including adjustments at the levels of enzyme activity and ion channel functionality.
AIBODY’s mission is to lead the charge in delivering transformative, high-impact digital twinning solutions for the healthcare sector globally. A stellar showcase of their capabilities is Nova Heart — a cardiology-centric digital twin developed in a prestigious partnership with the German Heart Centre at Charité (DHZC).
Data science for growers
The first automated tech solution for metadata in film
Smart wine investments
First true-to-life physiology platform accessible through the cloud
Unique compostable thermoplastic materials engineered for fashion application
World's first secure mobile personal health record
Capturing live music performances for later release in full multitrack studio quality
Intuitive employment platform connecting those looking to relocate with entry-level roles
Intuitive employment platform connecting those looking to relocate with entry-level roles
Medical production facility
Pre-production enhancement software
E-mobility solutions
E-mobility solutions
Multidisciplinary building technology and industrial robotics company
Digital queue and visitor flow management system
Modern and powerful B2B laundry and dry cleaning
The World's First and Only Sterile, Disposable, and Feminine Post-Surgical Bra
Mobile accounting app created for SMEs in Africa
Enabling faster identification of infections and sepsis for timely intervention
A new era in antimicrobial resistance (AMR)
%20(3).jpg)
